Subject
Neurology (clinical),Neurology,General Medicine
Reference10 articles.
1. Labeling of cannabidiol products: a public health perspective;Corroon;Cannabis Cannabinoid Res.,2020
2. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis;Freeman;Addiction,2021
3. French Council of State, 2022. L’interdiction de vendre à l’état brut des fleurs et feuilles provenant de variétés de cannabis sans propriétés stupéfiantes est suspendue (The ban on the sale of raw flowers and leaves from cannabis varieties without narcotic properties is suspended) [Internet, cited 2022 Feb 3]. Available from: https://www.conseil-etat.fr/actualites/l-interdiction-de-vendre-a-l-etat-brut-des-fleurs-et-feuilles-provenant-de-varietes-de-cannabis-sans-proprietes-stupefiantes-est-suspendue.
4. Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion?;Hughes;Addiction,2022
5. De jure decriminalisation of cannabis use matters: some recent trends from France;Massin;Int. J. Drug Policy,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献